https://rjrindex.com/articles/circulating-tumor-dna-and-late-recurrence-in-high-risk-hormone-receptor-positive-her2-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thymosin-alpha-1-enhanced-prag-regimen-a-novel-approach-to-boosting-immune-dynamics-and-therapeutic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-mutational-landscape-of-indian-core-binding-aml-an-answer-to-the-unfavorable-outcome-in-a-favora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-effectiveness-of-urine-dna-for-minimal-residual-disease-mrd-monitoring-of-urothelial-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tacti-004-a-double-blinded-randomized-phase-3-trial-in-patients-with-advancedmetastatic-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-in-targeted-therapy-of-gliomas-in-a-community-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-outcomes-with-darolutamide-in-the-phase-3-aranote-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-clinical-reasoning-and-accuracy-of-large-language-models-on-breast-oncology-multiple-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cutaneous-toxicity-and-clinical-outcomes-with-enfortumab-vedotin-and-pembrolizumab-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-combinations-in-patients-pts-with-erher2-locally-advanced-or-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-equal-study-utilizing-plasma-egfr-cfdna-detection-as-an-accessible-screening-tool-for-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-ocular-toxicities-in-patients-with-relapsedrefractory-multiple-myeloma-treated-with-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/litespark-029-a-phase-2-randomized-open-label-study-of-belzutifan-plus-fulvestrant-in-participant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/basecamp-1-an-approach-to-improve-patient-screening-efficiency-and-to-provide-large-datasets-for-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-genomic-landscape-of-estrogen-receptor-er-low-versus-er-positive-er-and-er-negativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-zavondemstat-tach101-a-first-in-class-kdm4-inhibitor-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-alliancea091802-randomized-trial-of-avelumab-plus-cetuximab-vs-avelumab-alone-in-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triplet-therapy-for-flt3-mutated-acute-myeloid-leukemia-in-puerto-rico-a-retrospective-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-trial-of-btm-3566-in-relapsedrefractory-mature-b-cell-lymphomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/suprame-a-phase-3-trial-comparing-ima203-an-engineered-t-cell-receptor-expressing-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontline-treatment-strategies-in-peripheral-t-cell-lymphoma-a-network-meta-analysis-of-efficacy-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-sirolimus-in-combination-with-metronomic-chemotherapy-choanome-in-children-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sacituzumab-tirumotecan-sac-tmt-in-combination-with-tagitanlimab-anti-pd-l1-in-first-line-1l-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-transfer-learned-hierarchical-variational-autoencoder-model-for-computational-design-of-anticancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-to-evaluate-the-safety-and-efficacy-of-xnw5004-a-selective-ezh2-inhibitor-in-sub 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-the-hfa-icos-cardiovascular-toxicity-risk-tool-in-chronic-myeloid-leukemia-patients-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-ribociclib-rib-endocrine-therapy-et-vs-combination-chemotherapy-combo-ct-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-pemigatinib-for-pre-treated-glioblastoma-or-other-gliomas-with-activating-fgfr1-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-a-phase-12-study-of-7mw3711-a-novel-b7-h3-antibody-drug-conjugate-adc-incorporating-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-liver-transplant-recipients-with-and-without-diabetes-a-propensity-matched-analysis-usi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-vs-sunitinib-for-first-line-treatment-of-advanced-renal-cell-carcinoma-fi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sequential-intravesical-gemcitabine-and-docetaxel-versus-bacillus-calmette-guerin-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/everest-2-initial-data-of-the-logic-gated-tmod-chimeric-antigen-receptor-t-cell-car-t-therapy-a2b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bladder-cancer-mortality-among-smokers-trends-and-disparities-in-us-adults-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-xalute-phase-3-study-of-xaluritamig-vs-investigators-choice-of-cabazitaxel-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-liposome-combined-with-anlotinib-as-second-line-treatment-in-patients-with-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-in-phase-i-trials-across-solid-tumors-and-hematological-malignancies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-on-combined-neo-adjuvant-intravenous-plus-intracranial-administration-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-liv-1-expression-with-clinical-efficacy-in-patients-with-advanced-breast-cancers-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imm2510-an-anti-pd-l1vegf-bispecific-antibody-fusion-protein-in-patients-with-rr-sts-a-phase-ib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-tucatinib-trastuzumab-and-capecitabine-ttc-following-trastuzumab-deruxtecan-t-dxd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-tumor-informed-cfdna-whole-genome-sequencing-to-capture-residual-disease-during-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pooled-analysis-of-clinical-outcomes-with-anti-pd1-based-neoadjuvant-immunotherapy-neoit-in-cuta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/substudy-c-of-the-canadian-cancer-trials-group-cctg-ind234-pc-bets-prostate-cancer-biomarker-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-obesity-on-the-survival-outcomes-among-indian-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-with-sacituzumab-govitecan-sg-based-therapy-in-metastatic-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-hv01-a-recombinant-human-il-21-expressing-oncolytic-vaccinia-virus-as-monotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-adar1-loss-in-lung-cancer-on-anti-tumor-immunity-and-tumor-cell-growth-via-the-rig-imda5-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-the-triglyceride-glucose-index-for-the-efficacy-of-immunotherapy-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-p57-in-cgas-sting-mediated-innate-sensing-and-immunotherapy-response-in-hepatocellular-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-conversion-surgery-after-immune-checkpoint-inhibitor-based-combination-therapy-in-initia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genome-wide-association-study-of-neurocognitive-outcomes-among-childhood-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-of-metastatic-merkel-cell-carcinoma-patients-pre-and-post-immunotherapy-era-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clonal-evolution-of-primary-lesions-vs-brain-metastasis-of-egfr-mutated-nsclc-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-and-long-term-survival-in-stage-iv-lung-adenocarcinoma-as-predicted-by-serial-3-d-explant-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-stage-iii-melanoma-treated-with-adjuvant-immunotherapy-with-a-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-aspiration-pneumonia-in-white-american-patients-hospitalized-with-nasop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-ipilimumab-plus-nivolumab-in-metastatic-merkel-cell-carcinoma-a-systematic-review-and-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-survival-outcome-comparison-of-a-minority-rich-population-with-dlbcl-treated-with-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proceade-pantumor-a-phase-1b2-multicenter-study-of-precemtabart-tocentecan-m9140-an-anti-ceaca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-cardiotoxicity-of-acalabrutinib-versus-chemoimmunotherapy-in-chronic-lymphocytic-leukem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anlotinib-combined-with-sintilimab-as-first-line-treatment-in-patients-with-advanced-non-clear-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-ntrk-testing-strategies-for-detecting-ntrk-fusions-in-solid-tumors-in-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-accuracy-and-efficiency-of-large-language-models-for-chart-review-in-cancer-genetics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiotherapy-followed-by-capox-and-tislelizumab-in-mss-locally-advanced-rectal-cancer-with-resectabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hif1a-macrophages-as-key-mediators-of-immune-suppression-and-recurrence-in-early-stage-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesothelioma-showdown-surgery-vs-chemo-when-the-numbers-dont-agree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-disease-and-gastrointestinal-cancers-mortality-trends-and-persistent-disparities-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-treatment-patterns-and-outcomes-of-hiv-associated-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fragmentation-of-cell-free-dna-cfdna-in-locally-advanced-rectal-cancer-larc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-value-of-septin-9-methylation-assay-in-the-diagnosis-of-early-stage-colorectal-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-therapy-with-serplulimab-lenvatinib-and-paclitaxel-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-muscle-mass-loss-on-survival-during-neoadjuvant-chemoradiotherapy-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-disparities-in-cancer-biomarker-knowledge-and-access-across-canada 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-withdrawal-for-fda-accelerated-approvals-of-anticancer-drugs-1992-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/step-1-a-sickkids-pilot-providing-upfront-financial-support-for-pediatric-and-adolescent-patients-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-darolutamide-versus-abiraterone-acetate-plus-prednisone-in-combination-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-cells-and-clinical-outcomes-in-men-with-metastatic-hormone-sensitive-prostate-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-clinical-harm-and-financial-waste-from-failure-to-deploy-personalized-medicine-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-post-mastectomy-radiation-therapy-for-patients-with-breast-cancer-after-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ia-study-to-estimate-the-radiochemical-and-radiation-safety-of-of-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-resilience-in-stress-management-within-patients-with-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-winpro-trial-a-window-of-opportunity-study-of-endocrine-therapy-with-and-without-prometrium-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-low-income-patients-with-early-onset-breast-cancer-an-analysis-of-the-nationa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-incidence-and-five-year-relative-survival-analysis-of-classical-hodgkin-lymphoma-in-childr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gender-and-ethnic-disparities-in-breast-cancer-and-cardiovascular-disease-related-mortality-in-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-patients-with-hyperlipidemia-and-early-onset-breast-cancer-an-analysis-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-lenvatinib-after-progression-on-immunotherapy-in-advanced-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-hiv-and-age-on-sociodemographic-characteristics-inpatient-metrics-and-complications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-robotic-navigation-system-for-ct-guided-lung-ablation-first-efficacy-and-safety-evaluation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kaposi-sarcoma-herpesvirus-kshv-subtypes-and-impact-on-survival-in-107-patients-with-kaposi-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-predictive-role-of-trail-gene-expression-in-immune-checkpoint-inhibitor-ici-treated-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-guideline-concordant-cancer-care-for-patients-with-limited-english-proficiency-a-mixed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-of-malignant-peripheral-nerve-sheath-tumor-of-the-trachea-mediastinum-and-other-respirato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-and-toxicity-of-human-mesenchymal-stem-cells-derived-from-anti-pd1-integrated-ipscs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-triple-negative-breast-cancer-survival-a-2000-2021-retrospective-seer-analysis-of-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ocular-toxicity-and-tolerability-of-bcma-directed-antibody-drug-conjugate-adc-therapy-in-relapsed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-gene-mutations-tmb-and-pd-l1-in-relation-to-ici-response-in-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/research-on-cancer-related-cognitive-impairment-a-national-institutes-of-health-nih-grant-portfol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-ibi110-and-sintilimab-in-combination-with-chemotherapy-in-resectable-locally-advanced-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-lip-oral-and-pharyngeal-cancer-across-three-decades-an-age-adjusted-gbd-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-and-efficacy-of-oral-5-fu-in-combination-with-pembrolizumab-and-cisplatin-as-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/folate-deficiency-anemia-in-patients-on-parp-inhibition-insights-from-a-large-single-center-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guard-02-safety-and-efficacy-of-prophylactic-use-of-novel-long-acting-g-csf-efbemalenograstim-a-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-standard-versus-extended-interval-dosing-of-pd-1pd-l1-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fusobacterium-nucleatum-on-nf-kbhif-1accl20-pathway-and-m2-macrophages-infiltration-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/left-atrial-appendage-closure-laac-in-cancer-patients-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-derived-ilt5-and-suppression-of-t-cell-immunity-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-from-nej045a-study-safety-and-efficacy-of-durvalumab-plus-carboplatin-and-etoposid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-cd28-klrg1cd8-t-cells-as-prognostic-indicators-in-advanced-nsclc-chemoimmunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-high-performance-blood-based-dna-methylation-test-for-early-detection-of-gastrointestinal-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-the-noggo-perception-phase-ii-investigational-study-of-pembrolizumab-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-complete-blood-cell-count-derived-inflammatory-biomarkers-in-patients-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mitotic-circulating-tumor-cells-with-clinical-outcomes-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-implementation-of-molecular-oncology-test-e-consult-at-the-va-north-texas-health-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/major-adverse-cardiovascular-complications-event-outcomes-in-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-and-regional-mortality-trends-in-patients-with-hypertension-and-hepatobiliary-cancer-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-external-beam-radiotherapy-on-hepatic-parenchymal-resection-rate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-primary-malignancies-cancer-specific-survival-and-disparities-in-enucleation-an-overvie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/textbook-outcomes-in-liver-surgery-a-decade-of-experience-at-a-cancer-dedicated-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dosing-tolerability-and-adverse-events-aes-in-dihydropyrimidine-dehydrogenase-idpy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-copy-number-variations-cnv-patterns-and-pseudotime-trajectories-in-high-grade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-a-novel-interdisciplinary-pharmacology-curriculum-in-a-hematologyoncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-2l-adc-strategies-in-triple-negative-breast-cancer-tnbc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/presentation-progression-and-survival-in-placental-site-trophoblastic-tumors-a-population-based-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-impact-of-substance-use-and-mental-health-disorders-on-cancer-care-in-urban-underserve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-pd-l1-prediction-in-nsclc-patients-using-3d-self-supervised-deep-learning-and-radiomics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-alkbh5-with-cisplatin-ga-nanodrug-to-investigate-platinum-sensitivity-in-resistant-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mesonephric-like-adenocarcinoma-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-systemic-therapy-vs-locoregional-therapies-in-hepatocellular-carcinoma-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-large-language-model-processed-unstructured-clinical-data-versus-manual-physician-revi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-the-prognostic-value-of-oncotype-rs-and-mammaprint-mp-in-postmenopausal-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-prostate-cancer-on-outcomes-of-patients-hospitalized-with-acute-myocardial-injury-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-effects-of-financial-toxicity-on-quality-of-life-among-hematopoietic-stem-cell-transpl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cdk46-inhibitor-toxicity-in-geriatric-subgroups-evidence-from-the-faers-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-relationship-between-insomnia-vasomotor-symptoms-and-nocturia-in-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-risks-of-surgeries-and-complications-in-von-hippel-lindau-disease-with-belzutifan-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastrointestinal-cancer-and-metabolic-syndrome-mortality-in-the-us-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-challenges-for-precision-medicine-and-evidence-based-oncology-in-genitourinary-tumors-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-progression-and-treatment-of-aml-using-the-thales-qsp-software-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-and-validation-of-potential-diagnostic-plasma-biomarkers-for-diffuse-gliomas-by-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-brain-radiotherapy-and-intrathecal-injection-of-thiotepa-combined-with-systemic-treatment-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-miscarriage-before-epithelial-ovarian-cancer-eoc-diagnosis-in-patients-carrying-germ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-peri-operative-study-of-fianlimab-cemiplimab-chemotherapy-versus-cemiplimab-chemothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/possibility-of-using-the-combination-of-everolimussorafenib-medications-in-the-treatment-of-childre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-aspyre-lung-on-cytology-specimens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multisite-validation-of-biomechanical-computed-tomography-for-osteoporosis-assessment-and-fracture-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modeling-the-economic-impact-of-a-ciz1b-biomarker-blood-test-for-lung-cancer-screening-in-high-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-observational-study-to-compare-speech-and-swallowing-outcomes-in-different-types-of-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-perceived-interpersonal-support-and-quality-of-life-among-adult-patients-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-survey-of-patients-understanding-on-the-genetic-tests-for-cancer-genetic-syndromes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-cytoplasmic-ar-v7-circulating-tumor-cell-ctc-detection-add-utility-in-predicting-ar-pathway-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-device-to-simultaneously-collect-standard-core-biopsies-and-dislodged-cancer-cells-from-soli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-overall-survival-os-with-talazoparib-tala-enzalutamide-enza-as-an-initial-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-pediatric-oncology-outcomes-in-the-occupied-palestinian-territories-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-barriers-to-implementing-survivorship-support-programs-for-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-liver-cirrhosis-on-demographics-and-outcomes-following-esophagogastroduodenoscopy-for-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-cost-implications-for-collection-and-storage-of-excess-autologous-hematopoietic-stem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/likelihood-of-colorectal-cancer-screening-by-poor-health-status-a-cross-sectional-analysis-of-the-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-role-of-cytarabine-based-regimens-in-mantle-cell-lymphoma-a-real-world-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd58-alterations-and-their-role-in-regulating-antitumor-immune-responses-in-diffuse-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/total-metabolic-tumor-volume-for-predicting-cytokine-release-syndrome-and-treatment-response-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/propensity-score-ps-comparison-between-lisocabtagene-maraleucel-liso-cel-plus-ibrutinib-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivoreach-integrated-study-to-demonstrate-similarity-of-jpb898-to-reference-nivolumab-in-combinatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-model-to-predict-future-breast-cancer-risk-after-er-positive-and-her 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-of-young-onset-breast-cancer-and-the-role-of-germline-pathogenic-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frequency-and-spectrum-of-brca-pathogeniclikely-pathogenic-variants-in-the-hispanic-population-of-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-patterns-for-second-primary-malignancies-among-human-papillomavirus-hpv-associated-first-prim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-autoimmune-hepatitis-non-infectious-gastroenteritis-and-colitis-among-patients-with-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-retrospective-analysis-of-the-mutation-and-co-mutation-landscape-of-erbb2-in-advanced-nsc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-overview-of-survival-and-demographic-disparities-in-primary-peritoneal-carcinoma-insights-from-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-efficacy-and-biomarker-analysis-from-a-phase-ii-trial-of-intensive-chemotherapy-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-disitamab-vedotin-monotherapy-versus-chemotherapy-in-bladder-preser 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-value-of-multiple-molecular-tumor-board-reviews-for-sequential-next-generation-sequenc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-pd-l1-expression-and-pd-1-cd8-t-cells-to-predict-immunotherapy-outcomes-in-esophageal-squa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-daprodustat-compared-to-standard-recombinant-human-erythropoietin-rhepo-in-treatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-apatinib-and-chemotherapy-as-neoadjuvant-therapy-for-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ex-vivo-liver-resection-and-auto-transplantation-for-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/full-coverage-therapy-for-converting-unresectable-advanced-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-demographic-profiles-and-predictors-of-survival-in-epithelioid-trophoblastic-tumors-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-dynamics-and-targeted-therapies-associated-with-genetic-mutations-in-patients-with-colorectal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/employing-novel-pan-cancer-targets-for-immunotherapy-in-leukemias-and-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-isatuximab-subcutaneous-sc-plus-carfilzomib-and-dexamethasone-isa-kd-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-with-paclitaxel-plus-ramucirumab-ptx-ram-switch-maintenance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-crc-now-a-disease-of-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iesr1i-mutations-and-associated-alterations-in-patients-with-estrogen-receptor-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-nec-gfpc-01-2022-a-multicenter-phase-ii-study-evaluating-the-efficacy-and-safety-of-the-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-apg-157-monotherapy-in-patients-with-locally-advanced-squamous-cell-carcinoma-of-head-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/completed-phase-1a-dose-escalation-study-of-the-first-oral-enpp1-inhibitor-rbs2418-immunotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bariatric-surgery-and-risk-of-gastrointestinal-and-hormone-sensitive-cancers-in-patients-with-metabo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sacituzumab-govitecan-sg-plus-nivolumab-n-in-patients-pts-with-muscle-invasive-urothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carica-papaya-leaf-extract-cple-versus-placebo-to-improve-chemotherapy-induced-thrombocytopenia-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-analysis-of-the-immunoadapt-trial-neoadjuvant-endocrine-therapy-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-asandeutertinib-ty-9591-in-advanced-nsclc-patients-with-egfr-positive-mutation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-adapted-therapy-guided-by-human-papillomavirus-hpv-circulating-tumor-dna-in-patients-with-hpv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-cancer-burden-in-developing-countries-a-comprehensive-analysis-of-globocan-data-2022 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastasis-incidence-trend-analysis-and-impact-on-survival-using-seer-database-2010-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-clinical-trial-barriers-in-lung-cancer-patient-reported-impact-of-resources-on-trial-par 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-neoadjuvant-pembrolizumab-infusion-and-pathologic-complete-response-among-patients-with-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhaled-kb707-a-novel-hsv-based-immunotherapy-as-a-monotherapy-in-patients-with-advanced-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tp53-mutation-as-a-prognostic-factor-in-metastatic-non-small-cell-lung-cancer-nsclc-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mgmt-status-with-survival-in-low-and-high-grade-idh-mutant-astrocytomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypofraction-radiotherapy-followed-by-immune-checkpoint-inhibitors-for-locally-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-egfr-mutations-in-non-small-cell-lung-cancer-in-hawaii-a-multi-center-epidemiology-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-peripheral-eosinophilia-as-a-biomarker-post-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparison-of-lutetium-177-vipivotide-tetraxetan-in-advanced-castration-resistant-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-177-lutetium-dotatate-177lu-dotatate-in-olfactory-neuroblastoma-onb-a-case-series 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-episeek-an-epigenomic-blood-based-assay-for-multicancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-cytarabine-consolidation-in-older-patients-with-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neo-era-01-a-multi-center-single-arm-phase-ii-study-with-neoadjuvant-therapy-of-haic-gemox-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-study-of-gcc19cart-a-novel-car-t-cell-therapy-for-metastatic-colorectal-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-pivotal-trial-of-microbubble-enhanced-transcranial-focused-ul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-xnw27011-a-claudin-182-targeting-antibody-drug-conjugate-with-topoisomerase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-lurbinectedin-plus-atezolizumab-as-second-line-treatment-for-advanced-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-patient-pt-characteristics-treatment-patterns-and-overall-survival-os-in-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-larotrectinib-in-patients-with-non-primary-central-nervous-system-trk-fusion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lenvatinib-plus-pembrolizumab-in-patients-with-recurrentmetastatic-salivary-gla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-double-blind-phase-23-study-of-ficerafusp-alfa-bca101-or-placebo-in-c-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-first-line-immune-checkpoint-inhibitors-with-chemotherapy-in-advanced-ebv-assoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-opioid-use-prior-to-pancreatic-cancer-diagnosis-on-overall-survival-insights-from-see 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-hepatic-artery-infusion-chemotherapy-and-transarterial-chemoembolization-combined-with-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-alternating-magnetic-field-therapy-on-quality-of-life-among-cancer-survivors-with-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-a-muscadine-grape-extract-supplement-to-decrease-fatigue-among-older-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-sexual-dysfunction-among-men-with-cancer-before-the-initiation-of-systemic-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multivariate-model-to-predict-delay-in-diagnosis-and-treatment-of-breast-cancer-in-pakistan-a-ret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-inflammatory-bowel-disease-on-outcomes-of-colorectal-cancer-patients-undergoing-open-resec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-impact-of-nivolumab-amp-ipilimumab-combination-therapy-vs-dabrafenib-amp-trametin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-disitamab-vedotin-in-combination-with-rc148-versus-albumin-bound-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-screening-and-detection-following-uspstf-recommendations-for-ages-45-49-insights 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-induction-chemoimmunotherapy-ici-with-cemiplimab-in-combination-with-cisplatin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-intraoperative-ex-vivo-electrical-impedance-measurements-for-oral-squamous-cell-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-evaluating-68ga-fapi-pet-uptake-heterogeneity-as-a-predictor-of-t-dxd-treatment-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-durvalumab-doxorubicin-and-ifosfamide-in-recurrent-andor-metastatic-pulmonary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methylation-specific-epigenetic-and-ctdna-biomarkers-in-prognosis-of-advanced-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-emp2-in-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-driven-approaches-for-predicting-t-cell-mediated-immunity-and-beyond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u01-substudy-01a-phase-12-study-of-pembrolizumab-plus-ifinatamab-deruxtecan-i-dxd-or-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-study-about-oral-nutrition-supplement-in-local-advanced-nasophar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-antibody-drug-conjugate-target-expression-on-tumor-derived-extracellular-vesicles-circu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-trial-of-exercise-as-first-line-therapy-for-hormone-receptor-hr-positive-advanced-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-propensity-score-matched-analysis-for-time-to-trabectedin-failure-in-advanced-myxoid-liposarcoma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adaptive-ai-driven-clinical-decision-making-in-oncology-through-digital-twins-and-large-scale-imagin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/measuring-pancreatic-cancer-spatial-conformation-to-predict-recurrence-risk-after-total-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-dostarlimab-in-combination-antiretroviral-therapy-refractory-hiv-associat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcatheter-aortic-valve-replacement-in-cancer-patients-with-chest-radiation-therapy-risks-and-ou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-association-with-treatment-outcomes-during-pediatric-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-b-cell-responses-in-high-grade-serous-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-obesity-paradox-in-triple-negative-breast-cancer-patients-receiving-neoadjuvant-immu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-dependent-prediction-model-using-modified-deepsurv-algorithm-for-dynamic-risk-assessment-of-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarkers-associated-with-outcomes-from-optimize-1-cd40-agonist-mitazalimab-with-mfolfirinox-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/host-immune-classifier-to-predict-survival-with-chemoimmunotherapy-in-pd-l1-50-metastatic-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-with-concurrent-chemoradiotherapy-in-resectable-esophagogastric-junction-ade 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-cardiovascular-outcomes-among-cancer-patients-receiving-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-safety-and-effectiveness-of-azacitidine-plus-venetoclax-versus-intensive-chemotherapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-review-of-relapse-after-allogeneic-stem-cell-transplant-for-myeloid-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/venetoclax-duration-outcomes-analysis-in-mdsaml-within-a-community-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-infiltration-of-hematopoietic-stem-cells-hsc-with-cell-proliferation-and-patient-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-stage-i-triple-negative-breast-cancer-tnbc-treated-with-or-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-preventable-acute-care-events-a-study-on-reducing-emergency-visits-and-hospitalizations-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-efficacy-of-targeted-microwave-ablation-in-patients-with-prostate-cancer-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensification-of-androgen-deprivation-therapy-adt-in-metastatic-hormone-sensitive-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-polyclonal-plasma-cells-in-myeloma-post-treatment-implications-on-outcome-and-effect-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-malignant-and-premalignant-conditions-in-lgbtqia-individuals-on-gender-affirming-hormo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-armed-oncolytic-adenovirus-on-immunotherapy-for-primary-and-metastatic-brain-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-kit-mutations-with-risk-of-central-nervous-system-cns-metastasis-met-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tobacco-smoking-as-a-risk-for-cutaneous-squamous-cell-carcinoma-in-skin-of-color 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-molecular-resistance-mechanisms-in-therapy-naive-nsclc-patients-a-retrospective-2-year-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-cabozantinib-or-lenvatinib-following-atezolizumab-plus-bevacizumzb-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-ctdna-and-other-biomarkers-in-patients-with-curatively-resected-stage-i-iii-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-class-tmbim6-therapeutics-overcoming-limitations-in-current-oncology-therapies-through-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-pancreatic-cancer-mortality-a-nationwide-analysis-from-1968-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pevonedistat-in-combination-with-carboplatin-and-paclitaxel-in-advanced-intrahep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-effectiveness-and-safety-of-rc48-adc-combined-with-pd-1-inhibitors-for-patients-with-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-surufatinib-s-plus-kn046-k-and-chemotherapy-in-first-line-1l-advanced-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-observational-phase-ii-clinical-study-evaluating-hepatic-artery-infusion-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-histopathologic-biomarker-for-predicting-frontline-immunotherapy-combination-outcomes-in-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-skills-training-cst-in-hematologyoncology-fellowships-results-from-a-multi-institu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-among-histological-subtypes-of-non-small-cell-lung-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-follicular-lymphoma-patients-hospitalized-with-viral-respiratory-illnesses-a-national-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-picture-of-biomarker-testing-in-metastatic-bladder-cancer-a-comprehensive-assessment-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-lysis-syndrome-on-clinical-outcomes-and-healthcare-burden-in-chimeric-antigen-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-salvage-radiotherapy-in-relapsedrefractory-large-b-cell-lymphoma-patients-following-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-enrollment-of-demographic-subgroups-in-us-clinical-trial-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-her3-in-nsclc-leveraging-continuing-education-to-bridge-the-gaps-between-evidence-and-pra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-dmmrmsi-h-colorectal-cancer-navigating-rapidly-evolving-oncologic-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sapanisertib-and-serabelisib-piktor-with-paclitaxel-and-a-diet-substudy-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lurbinectedin-for-small-cell-lung-cancer-sclc-response-patterns-and-survival-outcomes-by-line-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-tumor-informed-ctdna-to-de-escalate-treatment-or-monitoring-in-metastatic-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-colorectal-cancer-incidence-following-bariatric-surgery-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-thrombocytopenia-and-splenomegaly-in-locally-advanced-rectal-cancer-patients-receiving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-longer-the-better-how-tokenized-linkage-can-extend-observable-time-for-cancer-patients-in-heal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-in-patients-with-metastatic-bladder-cancer-a-cross-regional-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-sarcoma-care-in-a-developing-country-impact-of-centralization-and-long-term-international 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-nab-paclitaxel-based-chemotherapy-with-or-without-pd-1pd-l1-blockade-in-secon 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-surgery-on-the-prognosis-of-patients-with-locally-advanced-vulva-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-tislelizumab-in-patients-with-relapsed-or-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-incretin-mimetic-therapy-on-weight-change-in-patients-with-cancer-a-pan-cancer-analysis-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-profile-of-low-grade-diffuse-glioma-in-patients-followed-at-the-national-cancer-institute-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-for-hereditary-cancer-syndromes-among-newly-diagnosed-patients-with-solid-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-pbae-nanoparticles-for-immunological-reprogramming-in-clinically-relevant-humanized-mous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-personalized-medicine-in-primary-bladder-adenocarcinoma-pab-a-machine-learning-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-counseling-gc-in-the-era-of-next-generation-sequencing-ngs-to-diagnose-microsatellite-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/where-you-live-and-who-you-are-the-unequal-face-of-cancer-and-diabetes-mortality-in-the-united-stat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relationship-between-aperiodic-dynamics-and-transcriptomic-alterations-and-a-neural-signature-of-gli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-an-ai-enabled-prediction-of-prostate-cancer-pca-using-urine-based-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-of-indeterminate-potential-mutations-in-neuroendocrine-tumor-patients-cluster 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparisons-of-survival-outcomes-of-antibody-drug-conjugates-in-metastatic-breast-cancer-a-network 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-doris-a-cancer-focused-ai-knowledge-platform-for-diagnosis-and-treatment-information 2026-08-24 monthly 0.7 https://rjrindex.com/articles/larotrectinib-resistance-in-trk-fusion-cancers-analysis-of-a-tumor-agnostic-global-clinical-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atezolizumab-and-stereotactic-body-radiation-in-metastatic-recurrent-or-persistent-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-the-relationship-between-glutaminase-expression-and-features-of-the-immune-tumor-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-germline-and-somatic-landscape-of-uterine-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-a-patient-ambassador-program-to-improve-clinical-trial-knowledge-and-intent-to-discuss-gy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-survivorship-in-brazil-from-providers-perspectives 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-timing-of-diagnosis-and-breastfeeding-on-postpartum-breast-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microrna-based-signatures-of-early-and-late-immune-related-adverse-events-to-anti-pd1-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-study-on-splenic-radiation-dose-constraints 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-mortality-of-gastric-cancer-among-older-adults-70-from-1990-to-2021-across-204 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-phase-2b-study-of-selinexor-in-combination-with-carfilzomib-daratumumab-or-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-of-indian-dlbcl-ready-for-prime-time 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-following-upfront-surgery-vs-neoadjuvant-chemotherapy-for-triple-negative-and-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opioid-knowledge-and-concerns-challenges-among-physicians-in-turkey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-myelodysplastic-syndrome-in-patients-treated-with-parp-inhibitors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptional-dynamics-of-cd74-b-cells-in-tertiary-lymphoid-structures-and-effects-on-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicodemographic-predictors-of-enrollment-and-outcomes-in-early-phase-oncology-clinical-trials-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-second-line-treatment-in-patients-with-nsclc-and-targetable-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overcoming-acquired-venetoclax-resistance-in-acute-myeloid-leukemia-through-cell-metabolism-targetin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-transplant-measures-of-geriatric-assessment-domains-and-outcomes-of-allogeneic-hematopoietic-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-treatment-mri-to-predict-pathological-complete-response-in-triple-negative-breast-cancer-follow 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-predictors-of-treatment-free-remission-in-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-analysis-of-cfdna-samples-from-black-patients-with-metastatic-castration-resistant-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dipcan-a-multidimensional-approach-to-precision-oncology-harnessing-genomic-clinical-pathologica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-determinants-of-health-and-timely-chemotherapy-initiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metabolic-only-response-assessment-for-omission-of-residual-node-radiation-therapy-rnrt-for-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-effectiveness-and-safety-of-disitamab-vedotin-for-her2-expressing-advanced-or-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-atezolizumab-plus-bevacizumab-for-advanced-hepatocellular-carcinoma-in-relation-to-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-clinical-benefit-of-trastuzumab-deruxtecan-t-dxd-and-sacituzumab-govitecan-sg-in-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-biomarker-trial-of-pepinemab-to-enhance-nivolumab-or-ipilimumab-activity-in-resectable-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-geriatric-8-frailty-guideline-treatment-treatment-adherence-and-overall-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-chatgpt-4o-in-management-of-gynecologic-oncologic-patients-in-the-emergency-departmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soundtrack-e-a-phase-12-open-label-multicenter-study-to-evaluate-the-safety-and-efficacy-of-azd0 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-molecular-testing-and-targeted-therapy-utilization-among-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-complications-of-cd20-x-cd3-bispecific-antibody-therapy-in-patients-with-b-cell-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-outcomes-of-breast-cancer-subtypes-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-the-rkip-snail-yy1-axis-on-immune-evasion-in-gbm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myeloablative-fractionated-busulfan-conditioning-regimen-with-sorafenib-for-allogeneic-stem-cell-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-sacituzumab-govitecan-in-heavily-pretreated-metastatic-her2-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-casdatifan-plus-cabozantinib-expansion-cohort-of-phase-1-arc-20-study-in-previously-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-rilvegostomig-rilve-plus-chemotherapy-ctx-in-advanced-biliary-tract-cancer-btc-pri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-prediction-of-cytokine-release-syndrome-post-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1a1b-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-anti-tumor-activity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-surgeons-decision-to-multidisciplinary-tumor-board-consensus-evaluating-treatment-plan-modifi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-molecular-characterization-of-pediatric-soft-tissue-sarcomas-a-report-from-the-cog-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-real-world-progression-free-survival-rwpfs-using-a-multimodal-machine-learning-ml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-colorectal-cancer-incidence-and-mortality-in-appalachian-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alpha3-a-pivotal-phase-2-study-of-first-line-1l-consolidation-with-cemacabtagene-ansegedleucel-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-artificial-intelligence-ai-to-optimize-multidisciplinary-tumor-board-workflows-at-osf-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-corest-inhibitor-jbi-802-dual-epigenetic-modifier-of-lsd1hdac6-an-opport 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-improving-adjuvant-endocrine-therapy-persistence-improve-survival-outcomes-for-patients-with-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-assistance-software-for-her2-low-and-her2-ultralow-ihc-interpretation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infusion-product-characteristics-to-predict-response-to-tumor-infiltrating-lymphocyte-til-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-and-trends-in-gastric-cancer-incidence-mortality-and-stage-specific-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-trial-of-trastuzumab-deruxtecan-and-biology-driven-selection-of-neoadjuvant-treatment-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-factors-influencing-turnaround-time-tat-for-tissue-comprehensive-genomic-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologic-outcomes-of-organ-preservation-in-patients-with-rectal-adenocarcinoma-treated-with-total-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-single-nucleotide-polymorphisms-snps-in-ipdcd1i-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-analysis-of-dnv3-plus-toripalimab-and-chemotherapy-in-advanced-melanoma-an-open 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-screening-in-high-risk-never-smokers-with-artificial-intelligence-lc-shield-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cemiplimab-rwlc-survivorship-and-epidemiology-case-interim-results-from-a-prospective-study-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emiltatug-ledadotin-emi-le-a-b7-h4-directed-dolasynthen-antibody-drug-conjugate-adc-being-inves 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-dzd6008-a-4-supthsup-generation-egfr-tki-with-ful 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-ev-103-cohort-h-neoadjuvant-treatment-with-enfortumab-vedotin-ev-monotherapy-in-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-with-kras-g12c-inhibitors-in-metastatic-non-small-cell-cancer-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-study-evaluating-the-safety-and-efficacy-of-ivermectin-in-combination-with-balstilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/romiplostim-for-chemotherapy-induced-thrombocytopenia-cit-in-colorectal-gastroesophageal-and-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-sup68sup-ga-ny104-petct-with-sup18sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-incidence-and-therapeutic-regimen-altering-effects-of-immune-checkpoint-inhibitor-associated-per 2026-08-24 monthly 0.7 https://rjrindex.com/articles/melatonin-for-alleviating-cancer-related-fatigue-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-cfdna-levels-and-ctdna-detection-rates-in-patients-with-stage-ii-colon-cancer-screened 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alisertib-in-combination-with-endocrine-therapy-in-patients-with-hormone-receptor-positive-hr-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epha2-sirna-in-dopc-nanoliposomes-epharna-a-phase-i-clinical-trial-in-patients-with-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumab-plus-ipilimumab-nivoipi-vs-gemcitabine-carboplatin-gem-carbo-chemotherapy-for-previou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/versatile-002-overall-survival-of-hpv16-positive-recurrentmetastatic-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-efficacy-and-safety-of-iruplinalkib-wx-0593-in-alk-positive-advanced-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magnetic-resonance-imaging-mri-radiomics-as-predictor-of-clinical-outcomes-to-neoadjuvant-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-open-label-clinical-trial-to-evaluate-the-combination-of-cadonilimab-injecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-t-cell-therapy-related-cardiovascular-adverse-effects-a-national-inpatien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-psma-617-with-ipilimumab-ipi-and-nivolumab-nivo-in-metastatic-cast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-impact-of-sbrt-on-dendritic-cells-in-the-tumor-microenvironment-of-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-from-the-completed-dose-finding-part-of-phase-2-study-of-the-innate-cell-engager-acimtamig 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-artificial-intelligence-ai-as-a-clinical-decision-support-tool-for-lung-cancer-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop-2-expression-and-its-prognostic-impact-on-endometrial-cancer-a-real-world-data-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oregovomab-in-combination-with-non-platinum-chemotherapy-for-the-treatment-of-parp-inhibitor-and-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-patients-with-b-cell-precursor-acute-lymphoblastic-leukemia-receiving-inotuzumab-ozogami 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testosterone-replacement-therapy-for-fatigue-sexual-dysfunction-and-quality-of-life-in-older-men-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transarterial-therapy-combined-with-donafenib-plus-programmed-cell-death-prot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-risk-of-cytokine-release-syndrome-associated-with-the-use-of-antineoplastic-agents-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-egr1-mediated-glutamine-metabolic-reprogramming-through-mtor-signaling-pathway-on-pancreat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-her-2-expressing-solid-tumors-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-zg005-a-bispecific-antibody-targeting-pd-1-and-tigit-as-monotherapy-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-center-study-on-the-role-of-acsl4-in-invasion-and-metastasis-of-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-camrelizumab-cam-plus-low-dose-apatinib-combined-with-gemcitabine-and-cisplatin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-induction-chemotherapy-ict-followed-by-chemoradiotherapy-for-locally-advanced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-grade-serous-ovarian-cancer-differentiation-and-invasion-post-chemotherapy-role-of-nrf2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-fibroblast-activation-protein-inhibitor-fapi-o4-petct-versus-flurodeoxygl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-testing-in-primary-advanced-or-recurrent-endometrial-cancer-a-cost-effectiveness-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-obesity-paradox-in-endometrial-cancer-epidemiology-of-obesity-among-endometrial-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-usage-patterns-and-training-needs-of-generative-artificial-intelligence-among-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-diffuse-large-b-cell-lymphoma-mortality-among-older-adults-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/test-performance-of-a-dna-methylation-based-liquid-biopsy-biomarker-for-detection-and-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-prognostic-nutritional-index-pni-and-racial-disparities-in-dlbcl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-utility-of-one-step-nucleic-acid-amplification-in-detecting-sentinel-lymph-node-metastases-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inferring-fgfr-status-from-hampe-images-using-digital-pathology-to-identify-patients-for-early-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumabnivolumab-versus-standard-of-care-in-non-clear-cell-renal-cancer-results-of-the-sunnifor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-pd-l1-expression-and-irasi-mutations-and-association-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-the-tumor-marker-tm-cancer-antigen-153-ca-153-and-its-association-with-overall-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-implication-of-resting-natural-killer-cells-in-mesothelioma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rechallenge-with-epidermal-growth-factor-receptor-inhibitors-for-metastatic-colorectal-cancer-a-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-the-occurrence-of-second-primary-malignancies-spms-in-early-onset 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imm27m-a-humanized-fc-engineered-anti-ctla-4-antibody-in-patients-with-advanced-solid-tumors-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-ipik3cai-mutation-detection-methods-in-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-circulating-methylated-septin-9-for-pathologic-complete-response-to-neoadjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-profiling-of-hormone-receptor-positive-her2-negative-hrher2-metastatic-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/increasing-mortality-burden-in-patients-with-hypertension-and-colorectal-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/i-spy2-endocrine-optimization-pilot-eop-neoadjuvant-lasofoxifene-laso-in-molecularly-selected-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-prediction-of-response-to-neoadjuvant-chemotherapy-from-digitized-hampe-slides-of-pre-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-matters-real-world-evidence-of-increased-immunotherapy-toxicity-in-elderly-patients-from-a-braz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-a-multicomponent-navigation-program-to-reduce-time-intervals-to-treatment-initiation-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-1-dose-escalation-and-expansion-study-evaluating-the-safety-tolerability-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-maic-of-olutasidenib-olu-and-ivosidenib-ivo-in-isocitrat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-the-new-classification-of-hormone-receptor-positive-breast-cancer-based-on-the-genom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/subgroup-analysis-by-fitness-criteria-of-patients-pts-with-blastic-plasmacytoid-dendritic-cell-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-clinical-characteristics-and-survival-outcomes-in-russian-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-single-home-visit-on-distress-in-cancer-patients-undergoing-chemotherapy-a-comparative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-epigenetic-clocks-and-chemotoxicity-in-older-adults-with-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-large-language-models-on-trial-to-patient-matching-efficiency 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-mortality-due-to-myelodysplastic-syndromes-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arima-prediction-model-for-mortality-caused-by-metastatic-cancers-in-the-united-states-population-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-communication-model-to-facilitate-conversations-about-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/app-first-as-a-strategy-to-increase-new-patient-access-and-treatment-of-patients-with-gastrointestin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-immune-related-adverse-events-iraes-and-association-with-symptom-distress-score-by-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-methylated-mgmt-using-radiomic-imaging-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trifluridine-tipiracil-with-bevacizumab-in-refractory-metastatic-colorectal-cancer-with-a-convenient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interactions-between-polygenic-variants-and-clinical-factors-as-predictors-of-breast-cancer-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-global-and-regional-burden-of-breast-cancer-in-females-from-1990-2023-a-systematic-analysis-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-droplet-digital-pcr-ddpcr-assay-to-detect-mgmt-promoter-methylatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qualifying-adcs-and-multispecific-therapeutic-targets-with-a-novel-agentic-ai-insight-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iv-pharmacovigilance-study-of-biosimilar-drugs-in-cancer-a-colombian-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ia-study-to-estimate-the-radiochemical-and-radiation-safety-of-sup68gsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-mitochondrial-proteins-as-plasma-biomarkers-for-chromophobe-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-fruquintinib-combined-with-pd-1-inhibitors-and-chemotherapy-in-the-first-line-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-metastatic-urothelial-carcinoma-pts-discontinuing-enfortumab-vedotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-patient-characteristics-treatment-tx-patterns-and-clinical-outcomes-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-circulating-tumor-dna-analysis-as-predictor-of-efficacy-of-neoadjuvant-therapy-in-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-the-effectiveness-and-toxicity-of-atezolizumab-and-bevacizumab-as-first-line-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/two-decades-of-change-tracking-intrahepatic-cholangiocarcinoma-mortality-in-the-united-states-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-adoptive-tumor-infiltrating-lymphocyte-til-bst02-therapy-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-centre-stratified-open-randomized-comparator-controlled-parallel-group-phase-ii-trial-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-efficacy-and-safety-of-lenvatinib-vs-apatinib-in-combination-with-hepatic-arterial-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-low-value-cancer-treatments-in-medicare-advantage-versus-traditional-medicare-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-capecitabine-by-brcam-status-in-patients-with-early-stage-triple-neg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-abemaciclib-outcomes-in-routine-clinical-practice-experience-of-several-moscow-centers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/co-expression-network-based-analysis-of-gene-programs-contributing-to-immune-checkpoint-inhibitor-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-2ir-immune-response-score-in-histologic-subtype-urothelial-carcinoma-hsuc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monotherapy-of-envafolimab-in-patients-with-high-tumor-mutational-burden-advanced-solid-tumors-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/surgical-outcomes-of-lenvatinib-treatment-followed-by-liver-resection-for-large-advanced-hepatocellu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravenous-vitamin-c-as-an-adjunct-to-standard-therapy-in-pancreatic-ductal-adenocarcinoma-a-syste 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genetic-predisposition-to-low-grade-systemic-inflammation-with-cancer-related-fatigue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/azeliragon-a-rage-inhibitor-in-combination-with-temozolomide-and-radiotherapy-in-patients-with-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-ii-study-of-pembrolizumab-plus-lenvatinib-for-patients-with-unresectable-cutaneous-angiosa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-dose-escalation-results-of-the-wee1-inhibitor-azenosertib-a-in-combination-with-encorafe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combination-of-lurbinectedin-and-atezolizumab-in-a-humanized-mouse-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conut-score-as-a-predictor-of-venous-thromboembolism-in-high-risk-hospitalized-cancer-patients-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-focal-adhesion-kinase-to-mitigate-hepatotoxicity-induced-by-pd-1-inhibition-with-or-withou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-benign-cardiac-tumors-and-thromboembolic-events-analysis-of-the-2018-2022-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-and-pathological-features-and-therapeutic-outcomes-of-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gamma-secretase-inhibitors-and-desmoid-fibromatosis-lessons-from-a-real-world-comprehensive-genomi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-concentrations-and-blood-tumor-mutation-burden-as-biomarkers-of-outcomes-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-toxicity-of-nivolumab-and-ipilimumab-in-rare-cancer-brain-metastases-a-multi-center-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-pd-1-negative-wntv-catenin-regulators-and-positive-mhc-class-ii-antigen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-autoimmune-diseases-and-characteristics-of-solid-tumor-patients-on-immune-checkpoint-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-gegen-qinlian-tablets-in-attenuating-immune-related-adverse-events-in-nsclc-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-slide-histology-based-deep-learning-model-for-mismatch-repair-deficiency-prediction-in-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosomal-proteins-as-biomarkers-for-differential-diagnosis-of-pleural-effusion-etiologies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-plasma-methylated-dna-markers-for-detection-hpv-positive-oropharyngeal-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-steroid-for-enhancing-patients-recovery-after-head-and-neck-cancer-surgery-with-free-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-and-clinical-significance-of-high-risk-secondary-cytogenetic-abnormalities-at-first-relapse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-and-patients-characteristics-of-malignant-phyllodes-breast-neoplasms-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-surgical-modalities-for-stage-0-to-stage-ii-acral-lentiginous-melanoma-a-national-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-genomic-characteristics-of-her2-ihc-0-membrane-staining-breast-cancer-and-implicati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-implications-of-discordant-eber-and-ebv-dna-status-in-nasopharyngeal-carcinoma-in-endemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-chemotherapy-drug-cisplatin-on-the-efficacy-of-b7h3-car-t-cells-in-treating-melanoma-by-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-mutations-in-lung-cancer-a-perspective-from-the-mexican-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-abemaciclib-to-endocrine-therapy-versus-endocrine-therapy-alone-in-hrher2-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-apatinib-following-concurrent-chemoradiotherapy-in-high-risk-nasopharyngeal-carcinoma-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-changes-in-salivary-cd44-and-total-protein-in-patients-with-oral-and-oropharyngeal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/end-of-life-care-for-newly-diagnosed-diffuse-large-b-cell-lymphoma-patients-with-poor-survival-outco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-meta-analysis-of-cisplatin-dosing-schedules-in-definitive-chemoradiotherapy-for-locoregi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-mortality-trends-among-patients-with-lip-and-oral-cavity-cancer-due-to-tobacco-consumption 2026-08-24 monthly 0.7 https://rjrindex.com/articles/distinct-effect-of-neoadjuvant-pd1-alone-pd1ipi-and-pd1lenvatinib-in-the-peripheral-immune-profi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-tracheal-bronchus-and-lung-cancer-attributable-to-occupational-carcinoge 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-gallbladder-cancer-related-mortality-in-the-united-states-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-to-anti-pd-1-immunotherapy-for-stage-iii-and-iv-melanoma-results-from-a-global-multi-sit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-outcome-analysis-of-recurrent-versus-de-novo-metastatic-pancreatic-ductal-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-treatment-positron-emission-tomography-image-quality-and-inter-fractional-tumor-uptake-variation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-knowledge-gap-regarding-radiopharmaceuticals-in-patient-communities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/muscle-mass-evaluation-among-ambulatory-cancer-patients-in-china-comparison-of-different-methods-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-minimal-residual-disease-detection-a-tumor-informed-whole-genome-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-fruquintinib-combined-with-envafolimab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-pancreatic-cancer-fibrosis-based-on-ct-images-and-its-association-with-chemotherapy-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-second-line-therapy-by-envafolimab-combined-with-anlotinib-and-s-1-in-pancrea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-comprehensive-cfdna-methylation-signature-for-prognostic-predictive-and-diagnosti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-health-system-for-resolving-breast-cancer-screening-actions-multicenter-randomized-clini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-health-related-quality-of-life-between-low-income-latino-and-white-men-with-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-clinical-factors-associated-with-care-outcomes-in-hospitalized-patients-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/project-shirley-fear-of-recurrence-and-risk-communication-in-australian-hr-her2-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-racial-disparities-in-oropharyngeal-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-first-line-chemotherapy-plus-nivolumab-in-gastric-and-gej-adenocarcinoma-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-gastric-cancer-mortality-in-the-us-a-population-based-analysis-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/30-year-trends-in-racial-disparities-for-early-stage-lung-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-post-allogeneic-hematopoietic-stem-cell-transplant-hsct-maintenance-therapy-in-flt3-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-venetoclax-combined-with-hypomethylating-agents-in-acute-myeloid-leukemia-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-incidence-mortality-and-survival-trends-in-acute-lymphoblastic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/at-risk-cancer-genetic-syndrome-identification-arcagen-id-novel-ehr-integrated-system-to-overcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-barriers-to-timely-nsclc-treatment-a-northern-nevada-perspective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-influencing-completion-of-cancer-therapy-in-heart-transplant-recipients-with-de-novo-maligna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-for-locally-advanced-sinonasal-carcinoma-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-post-discharge-palliative-care-pilot-clinic-for-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-phenotypes-and-management-of-patients-with-musculoskeletal-immune-related-adverse-events-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-circulating-tumor-dna-dynamics-during-and-after-infusional-therapy-initiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-results-of-esg401-a-trop2-targeting-adc-updated-phase-1-analysis-in-advanced-solid-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-for-clinical-stage-iii-melanoma-a-community-cancer-centers-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-evaluation-of-an-ai-powered-system-for-clinical-trial-eligibility-using-mcode-data-stand 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-study-of-safety-and-efficacy-in-vivo-of-a-yttrium-90-resin-microspheres-glue-formulation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accrual-of-historically-underrepresented-patients-with-multiple-myeloma-using-centralized-screening 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-surgical-outcomes-of-neoadjuvant-targeted-therapy-in-anaplastic-and-differentiated-thyr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alliance-a221805-duloxetine-to-prevent-oxaliplatin-induced-chemotherapy-induced-peripheral-neuropat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-co-culture-system-to-validate-results-of-a-phase-i-trial-testing-new-treatment-for-barretts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mid-treatment-positron-emission-tomography-adaptive-radiotherapy-in-stage-iii-non-small-cell-lung-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linvoseltamab-linvo-bortezomib-btz-in-patients-pts-with-relapsedrefractory-multiple-myeloma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/salvovar-a-pragmatic-randomized-phase-iii-trial-comparing-the-salvage-weekly-dose-dense-regimen-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interrogating-the-interleukin-6-il-6il-23t-helper-th17-axis-in-immunotherapy-toxicity-mechani 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-fruquintinib-versus-regorafenib-and-trifluridinetipiracil-in-treating-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-biomarkers-as-predictors-of-response-to-mosunetuzumab-in-previously-untreated-follicular-fl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/functional-and-survival-outcomes-in-hpv-positive-oropharyngeal-squamous-cell-cancer-treated-with-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/simrise-a-randomized-phase-iii-trial-evaluating-sim0270-in-combination-with-everolimus-versus-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimating-the-access-to-psychotherapy-and-psychological-support-for-cancer-patients-in-nigeria-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-dose-escalation-and-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-axitinib-nivolumab-in-mucosal-melanoma-with-pilot-addition-of-stereotactic-body-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-body-mass-index-bmi-on-efficacy-and-safety-of-abemaciclib-in-breast-cancer-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lifileucel-in-patients-with-advanced-melanoma-5-year-outcomes-of-the-c-144-01-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-clinical-study-of-adebrelimab-and-bevacizumab-combined-with-cisplatincarboplatin-in-trip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-center-study-of-efficacy-and-safety-of-capivasertib-in-hormone-receptor-positive-hr-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-landscape-of-resistance-to-next-generation-alk-inhibitors-with-evolving-treatment-paradigm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-to-identify-predictive-biomarkers-and-highlights-the-potential-efficacy-of-il-6r-bl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-lb1410-a-bivalent-tim-3pd-1-bispecific-antibody-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigating-artificial-intelligence-ai-accuracy-a-meta-analysis-of-hallucination-incidence-in-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypoxia-inducible-factor-2a-hif-2a-inhibitor-belzutifan-in-von-hippel-lindau-vhl-disease-associa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mhb088c-a-novel-b7-h3-targeted-adc-in-patients-with-relapsed-extensive-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-cohort-based-prediction-model-for-early-relapse-of-hepatocellular-carcinoma-post-surgery 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lurbinectedin-lurbi-atezolizumab-atezo-as-first-line-1l-maintenance-treatment-tx-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-of-mc200710-investigating-therapeutic-vaccine-pds0101-alone-or-with-pembrolizumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-dose-expansion-study-of-zg006-a-trispecific-t-cell-engager-targeting-cd3dll3dll3-as-mo-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fedratinib-in-myelofibrosis-patients-after-ruxolitinib-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-encorafenib-and-cetuximab-ec-beyond-progression-in-combination-with-folfiri-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pimicotinib-in-tenosynovial-giant-cell-tumor-tgct-efficacy-safety-and-patient-reported-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-for-zanidatamab-hrii-compared-to-chemotherapy-in-previously-treated-her2-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-an-academic-precision-oncology-service-in-a-community-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/redefining-criteria-for-omitting-axillary-surgery-following-neoadjuvant-systemic-therapy-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-age-on-financial-toxicity-among-breast-cancer-patients-with-resectable-invasive-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pleomorphic-lobular-carcinoma-in-situ-upgrade-rate-to-invasive-carcinoma-association-with-other-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-answers-impact-of-a-quality-improvement-initiative-for-lung-cancer-pathology-practices 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-examination-of-national-changes-in-potentially-avoidable-hospital-visits-after-chemotherapy-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-multi-level-social-determinants-for-disparities-in-survival-and-patient-reported-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/point-of-care-social-needs-screening-and-resource-navigation-for-patients-with-cancer-undergoing-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-the-clinic-comprehensive-assessment-of-time-burdens-in-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-nivolumab-in-advanced-esophageal-carcinoma-a-systematic-review-of-phase-iii-clinical-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-young-onset-colorectal-cancer-patients-with-an-accessible-self-navigable-online-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-lymphatic-ablation-approaches-on-immunotherapy-efficacy-in-esophageal-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-of-doacs-in-budd-chiari-syndrome-a-real-world-comparison-from-the-trinetx-global-collaborati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-cancer-support-and-technology-in-breast-cancer-care-developing-a-chatbot-for-underserve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-phase-2-study-of-prolonged-neoadjuvant-immunotherapy-plus-chemotherapy-in-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/equitable-access-for-management-of-pre-invasive-cervical-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-genomic-mechanisms-of-health-disparities-among-adolescentyoung-adult-survivors-of-hodgkin-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-shortcut-from-ovarian-cancer-development-to-metastasis-ii-imycfas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tracking-incidence-and-prognosis-of-lung-cancer-seen-in-kidney-transplant-recipients-a-retrospectiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-human-immunodeficiency-virus-on-hepatocellular-carcinoma-outcomes-a-national-inpatient-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-distinct-regimens-for-individuals-with-advanced-egfr-mutated-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcome-analysis-of-the-two-mcgill-university-associated-hospitals-with-lu-177-prrt-for-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-global-burden-and-trend-of-cervical-cancer-in-g20-countries-age-sex-regional-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacologic-and-pharmacometric-studies-of-factors-affecting-the-pharmacokinetics-and-pharmacodynam 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-genomic-testing-in-prostate-cancer-a-comprehensive-system-wide-initiative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oropharynx-cancer-in-the-us-racial-disparities-in-stage-at-presentation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-pfs-assessment-by-blinded-independent-central-review-bicr-versus-local 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-rna-biomarkers-for-the-differential-diagnosis-of-cutaneous-melanoma-and-nevi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transforming-kidney-cancer-treatment-through-ai-enabled-functional-precision-medicine-the-pear-tree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/homologous-recombination-deficiency-signature-hrdsig-in-advanced-cutaneous-melanoma-acm-a-genom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-and-correlates-of-cancer-cachexia-in-the-detroit-research-on-cancer-survivors-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-and-multi-institutional-cancer-symptom-management-strategies-in-the-veterans-affai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-molecular-predictors-of-radiotherapy-combined-with-bevacizumab-on-desmoid-tumor-aggres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/can-lymph-node-next-generation-sequencing-assist-in-better-predicting-the-prognosis-of-lung-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integration-of-cfdna-fragmentomics-for-early-biliary-tract-cancer-detection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insihgt-revived-unified-3d-tissue-profiling-for-spatially-resolved-multi-marker-quantitative-expr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matching-adjusted-indirect-comparison-of-bireociclib-plus-fulvestrant-versus-abemaciclib-plus-fulves 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-role-of-dietary-interventions-in-reducing-chemotherapy-toxicities-in-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-response-at-apheresis-and-association-with-long-term-outcomes-following-car-t-cells-for-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-adjuvant-regimens-with-single-cytotoxic-agents-among-women-with-stage-ii-iii-her2-positive-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-importance-of-routine-g6pd-screening-in-oncology-patients-a-prospective-comparative-study-in-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eribulin-plus-anlotinib-in-advanced-soft-tissue-sarcoma-eras-updates-on-efficacy-and-biomarkers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipcdhgb7i-a-universal-cancer-only-marker-ucom-and-novel-diagnostic-tool-for-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-outcomes-in-pancreatic-mucinous-adenocarcinoma-pma-using-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-the-association-between-nivolumab-exposure-and-efficacy-in-patients-with-metas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tops-trainees-in-oncology-programs-a-professional-development-curriculum-for-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-do-no-harm-evaluating-clinical-skills-for-patient-safety-in-oncology-fellows 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-psma-radio-genomics-in-hormone-sensitive-synchronous-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-comparison-of-abatacept-aba-and-half-dose-posttransplant-cyclophosphosphamide-ptcy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-awareness-in-older-adults-with-metastatic-cancer-secondary-analysis-of-a-randomized-cont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-overall-survival-in-adults-with-cancer-in-the-us-using-machine-learning-approaches-integr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facilitating-precision-medicine-in-the-community-oncology-setting-artificial-intelligence-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-social-needs-in-an-urban-academic-breast-cancer-survivorship-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-patients-with-synchronous-cancers-in-west-virginia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-implementation-model-of-the-organized-screening-strategy-using-the-pcr-dna-molecular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-proximity-to-health-center-on-adherence-to-nccn-guidelines-in-patients-with-soft-tissue-sa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-elderly-patients-with-early-stage-triple-negative-breast-cancer-treated-with-the-keynote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-novel-circulating-tumor-cell-response-stratification-criteria-for-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-event-free-survival-efs-of-stromal-tumor-infiltrating-lymphocytes-stils-pd-l1-expre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fibroblast-activating-protein-fap-expression-and-first-clinical-utility-of-sup68su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-of-prostate-cancer-in-38-oecd-countries-and-its-trend-from-1990-2021-an-insight-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-acute-side-effects-of-salvage-radiotherapy-in-biochemical-recurrence-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-low-status-on-pathologic-response-after-neoadjuvant-chemotherapy-in-tnbc-a-large-sca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-proliferation-gene-signatures-and-stromal-tumor-infiltrating-lymphocytes-sti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-immuno-profiling-predicting-t-and-b-cells-directly-from-hampe-stained-slides 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-effectiveness-of-treatment-cost-calculation-tool-in-improving-patients-understanding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-overall-survival-in-the-south-african-breast-cancer-and-hiv-outcomes-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fico-scores-and-borrowing-patterns-among-hematology-oncologists-compared-to-other-medicine-subspecia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-vista-expression-in-patients-with-malignant-pleural-mesothelioma-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-radiation-as-a-nonsurgical-option-after-chemoimmunotherapy-for-stage-iii-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hematologic-toxicities-with-axicabtagene-ciloleucel-for-b-cell-lymphomas-in-a-majority-minority-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-car-t-in-the-outpatient-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-on-efficacy-and-safety-of-trifluridine-tipiracil-and-bevacizumabin-refractory-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-factors-for-refractory-metastatic-colorectal-cancer-treated-with-trifluridine-tipirac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncokb-automated-annotation-of-the-pathogenicity-and-treatment-implications-of-germline-mutations-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-immune-checkpoint-inhibitors-as-first-line-therapy-for-untreated-unresectable-pleural-mesoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-of-gastrointestinal-secondary-primary-malignancy-in-chronic-lymphocytic-leukemia-patients-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-deep-learning-for-automated-recognition-of-immune-cells-interacting-with-ctcs-for-progno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whats-weight-got-to-do-with-it-in-hospital-outcomes-in-colorectal-cancer-patients-with-and-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-factors-associated-with-advanced-colorectal-neoplasia-in-average-risk-asymptomatic-individ-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-cancer-spectrum-among-breast-cancer-patients-with-tp53-germline-mutatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-clinical-characteristics-and-immunotherapy-outcomes-in-chinese-patients-with-merkel-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-plus-bevacizumab-oxaliplatin-and-capecitabine-as-perioperative-therapy-in-microsatellit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-alliance-a022104nrg-gi010-a-randomized-phase-iiiii-trial-testing-the-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-lifestyle-profiles-of-healthy-aging-survivors-a-report-from-the-childhood-cancer-surv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-plasma-cell-free-dna-and-tissue-next-generation-sequencing-ngs-in-detecting-genetic-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-pembrolizumab-plus-cisplatin-and-5-fu-chemotherapy-followed-by-chemoradiotherapy-in-locall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intrk1-3i-point-mutations-in-non-small-cell-lung-cancer-molecular-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-molecular-and-immune-characterization-of-adrenergic-stress-signaling-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-analysis-of-neoadjuvant-pd-1-inhibitor-combined-with-chemotherapy-in-various-subanatomical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-of-patients-with-hiv-and-squamous-cell-carcinoma-of-the-anal-canal-scac-treated-with-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tislelizumab-as-adjuvant-therapy-following-endoscopic-surgery-for-resectable-recurrent-nasopharyngea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-innovation-to-impact-how-new-therapies-and-racial-disparities-shaped-melanoma-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pre-existing-cancer-as-a-risk-factor-for-poor-outcomes-after-burn-injury 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-heart-failure-with-abiraterone-versus-enzalutamide-amongst-patients-diagnosed-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-biomarker-based-treatment-strategy-in-patients-with-recurrentmetastatic-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-of-early-stage-colorectal-cancer-using-multiplexed-extracellular-vesicle-proteomic-biomark 2026-08-24 monthly 0.7 https://rjrindex.com/articles/free-flap-surgery-for-oral-squamous-cell-carcinoma-postoperative-complications-and-its-association 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-evaluating-the-addition-of-cemiplimab-in-braf-mutant-anaplastic-thyroid-cancer-after-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-precision-therapeutics-in-follicular-thyroid-cancer-insights-from-the-aacr-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-patterns-in-car-t-therapy-utilization-inpatient-mortality-and-adverse-event 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-lysis-syndrome-in-lung-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/missing-data-and-missed-opportunities-inability-to-perform-secondary-analysis-of-prospective-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lacutamab-in-patients-with-relapsed-andor-refractory-mycosis-fungoides-long-term-follow-up-and-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-characteristics-and-survival-outcomes-of-pediatric-clear-cell-sarcoma-of-the-kidney-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-an-artificial-intelligence-based-tool-to-predict-financial-toxicity-early-to-facilitate-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-anti-pd-1-rechallenge-in-metastatic-melanoma-a-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pucotenlimab-in-high-microsatellite-instabilitymismatch-repair-defificient-msi-h-dmmr-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-and-transcriptome-landscape-of-actionable-driver-negative-lung-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-transcriptomic-analysis-to-identify-similarities-and-therapeutic-vulnerabilities-in-olfa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-docking-investigating-methotrexate-as-a-potential-target-for-addressing-cardiovascular-dis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-epidemiology-of-acute-ischemic-stroke-in-breast-cancer-patients-admitted-to-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-and-outcomes-of-breast-cancer-with-leptomeningeal-disease-real-world-experience-in-the-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-based-kidney-injury-molecule-1-kim-1-as-a-diagnostic-and-prognostic-indicator-in-renal-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transcriptomic-insights-into-the-prognostic-role-of-mean-platelet-volume-and-ferroptosis-in-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-on-the-application-of-fgfr-inhibitors-in-metastatic-bladder-cancer-a-multinational 2026-08-24 monthly 0.7 https://rjrindex.com/articles/javemacs-chart-review-study-of-avelumab-maintenance-in-patients-with-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-center-experience-with-neoadjuvant-chemoimmunotherapy-versus-chemotherapy-in-patients-with-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcome-of-trastuzumab-derutexcan-t-dxd-in-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-1-trial-with-expansion-cohort-of-botensilimab-agen1181-balstilimab-agen203 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ex-vivo-3d-micro-tumor-testing-platform-for-predicting-clinical-response-to-platinum-based-therapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-hiv-on-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma-treated-with-cd19-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-due-to-myelodysplastic-syndromes-from-1999-to-2020-a-cdc-wonder-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alcohol-use-and-subsequent-primary-cancer-in-breast-cancer-survivors-a-case-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-trial-of-intrapleural-drug-loaded-vesicle-perfusion-combined-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-the-efficacy-and-safety-of-regorafenib-monotherapy-and-regorafenib-combination-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/landscape-of-genomic-alterations-in-genes-implicated-in-the-regulation-of-hypoxia-inducible-factor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-ereach-study-a-randomized-study-of-an-ehealth-delivery-alternative-for-cancer-genetic-testing-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predication-of-clinical-outcomes-of-advanced-cutaneous-squamous-cell-carcinoma-to-pd1-inhibition-dir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-of-prognostic-models-for-cardiomyopathy-and-heart-failure-applicable-to-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-driven-strategy-following-isakrd-induction-in-transplant-eligible-ndmm-primary-endpoints-of-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/second-primary-malignancy-spm-in-patients-pts-with-multiple-myeloma-mm-receiving-chimeric-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-long-term-toxicities-of-imatinib-in-cml-experience-from-a-tertiary-care-cancer-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-ipilimumab-combination-therapy-in-advanced-hepatocellular-carcinoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fear-of-recurrence-among-uninsured-and-underrepresented-prostate-cancer-survivors-of-the-mens-healt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-epigenomic-biomarkers-and-baseline-clinical-characteristics-in-patients-with-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-integrating-polygenic-risk-scores-with-breast-cancer-risk-assessment-models-resu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-erbb2-activating-mutations-on-enhanced-internalization-and-activity-of-trastuzumab-deruxte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-results-of-sure-02-a-phase-2-study-of-neoadjuvant-sacituzumab-govitecan-sg-plus-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postmarketing-safety-profile-of-chimeric-antigen-receptor-car-t-cell-therapies-in-diffuse-large-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-tumor-mutational-burden-assessment-using-target-enhanced-whole-genome-sequencing-a-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-safety-and-efficacy-study-of-prt3789-in-combination-with-pembrolizumab-in-patients-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-randomized-placebo-controlled-study-of-fisetin-and-exercise-to-mitigate-chemotherapy-rela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-the-efficacy-of-atezolizumab-and-bevacizumab-in-unresectable-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-outcomes-pros-in-locally-advanced-cervical-cancer-lacc-insights-from-the-outba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complexities-of-managing-refractory-hypoglycemia-in-a-rare-case-of-metastatic-grade-2-pancreatic-neu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-idecabtagene-vicleucel-in-relapsed-refractory-multiple-myeloma-without 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ai-assisted-pd-l1-cps-scoring-in-immunostained-pan-organ-tumor-whole-slide-images 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-misinformation-and-trust-in-doctors-and-scientists-among-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-plk1-inhibitor-onvansertib-in-combination-with-paclitaxel-in-metastatic-triple-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-baseline-plasma-circulating-tumor-dna-ctdna-to-predict-duration-of-endocrine-therapy-et-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longer-follow-up-for-survival-and-safety-from-the-evoke-01-trial-of-sacituzumab-govitecan-sg-vs-do 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-randomized-trial-keynote-630-of-adjuvant-pembrolizumab-pembro-versus-placebo-pbo-for-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debio-0123-a-highly-selective-wee1-inhibitor-in-adult-patients-with-advanced-solid-tumors-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-unruptured-abdominal-aortic-aneurysm-aaa-diagnosis-on-risk-of-malignant-neoplasms-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-advantages-of-thymosin-a1-combined-with-toripalimab-for-elderly-patients-with-advanced-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fierce-hn-a-multicenter-randomized-double-blind-placebo-controlled-phase-3-study-of-ficlatuzuma-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonal-hematopoiesis-in-patients-with-non-hematologic-cancers-prevalence-and-detectability-in-prima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-pharmacokinetics-and-clinical-activity-of-rg6344-in-patients-with-braf-v600e-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-genetic-mutations-associated-with-pathological-complete-response-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-afnt-211-autologous-cd4-supsup-and-cd8 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-monotherapy-in-advanced-her2-positive-or-her2-lowultralow-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vilastobart-xtx101-a-tumor-activated-fc-enhanced-anti-ctla-4-monoclonal-antibody-in-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-ibrutinib-plus-venetoclax-in-patients-with-mantle-cell-lymphoma-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-soft-tissue-sarcoma-surveillance-the-role-of-ctdna-testing-in-early-detection-and-monitor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/re-evaluation-of-her2-status-and-prognostic-implications-of-ultra-low-and-low-her2-expression-in-est 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-multicenter-phase-3-study-of-vusolimogene-oderparepvec-combined-with-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-feasibility-of-personalized-and-tumor-informed-ctdna-assay-for-early-recurrence-detection-in-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-deep-proteomics-into-precision-oncology-for-multi-omics-characterization-of-metastatic-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-systemic-regimen-to-choose-in-cisplatin-ineligible-patients-with-concurrent-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reframing-hormone-positive-dcis-management-effects-of-adjuvant-therapies-and-surgical-extent-on-any 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-bromodomain-and-extra-terminal-bet-inhibitor-incb057643-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumab-and-nivolumab-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-treate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/blastic-plasmacytoid-dendritic-cell-neoplasm-bpdcn-prognostic-factors-and-outcomes-in-68-mayo-cli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/triple-negative-breast-cancer-remodeling-of-the-tissue-immune-microenvironment-by-regulation-of-embr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/worldwide-experience-of-chronic-active-ebv-infection-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-her2-ultralow-heterogeneity-and-optimal-threshold-on-trastuzumab-deruxtecan-t-dxd-effica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-lanreotide-as-a-therapy-for-pheochromocytomas-pcs-and-paragangliomas-pgs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/luminosity-a-phase-2-study-of-telisotuzumab-vedotin-in-patients-with-c-met-protein-overexpressing-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-lm-302-anti-claudin-182-adc-in-combination-with-anti-pd-1-therapy-for-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monocentric-pilot-trial-of-trametinib-in-severe-extracranial-arteriovenous-malformations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-safety-and-efficacy-of-sotorasib-plus-panitumumab-and-folfiri-for-previously-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-combined-with-hypofractionated-radiotherapy-and-chemotherapy-for-locally-recurrent-rec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-differences-in-non-metastatic-breast-cancer-outcomes-by-tumour-subtype-real-world-data-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-all-oral-regimen-of-decitabine-cedazuridine-dec-c-plus-venetoclax-ven-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-histological-subtypes-in-patients-receiving-first-line-treatment-with-enfortumab-vedotinp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nautilus-a-phase-1b2-trial-of-combining-oral-hdac-inhibitor-hdaci-with-mek-inhibitor-meki-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ib-trial-of-the-sirpa-inhibitor-bi-765063-in-combination-with-the-pd-1-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-dyp688-an-antibody-drug-conjugate-delivering-a-direct-gq11-inhibitor-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-trastuzumab-pkrb-plus-gedatolisib-in-patients-with-her2-positive-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-ribociclib-plus-endocrine-therapy-in-hr-positive-her2-negative-early-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-viral-and-non-viral-etiologies-of-hepatocellular-carcinoma-hcc-in-the-us-over-time-by 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-and-disparities-in-polycythemia-vera-mortality-in-the-us-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-testicular-cancer-survival-outcomes-a-seer-database-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shorespan-007-phase-3-study-of-bomedemstat-versus-hydroxyurea-in-essential-thrombocythemia-naive-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rechallenge-with-first-generation-ret-inhibitors-in-ireti-rearranged-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-osimertinib-with-and-without-radiation-therapy-in-egfr-mutated-non-small-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-immune-related-adverse-events-irae-in-gastrointestinal-malignancies-gi-m-tumor-speci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delineation-of-immunotherapeutic-predictive-versus-prognostic-transcriptional-programs-to-identify-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-irinotecan-together-with-vincristine-and-temozolomide-naliri-vt-for-patients-with-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-plus-anti-pd-1-or-anti-pd-l1-in-advanced-pd-l1-negative-squamous-cell-lung-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiomic-phenotypes-of-tumor-angiogenesis-compared-with-pd-l1-in-pre-treatment-prediction-of-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-mortality-dynamics-uncovering-critical-disparities-in-us-population-health-201 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-of-colorectal-cancer-in-adolescents-and-young-adults-aya-at-a-tertiar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axalap-phase-ib-study-of-axatilimab-in-combination-with-olaparib-in-ibrca12i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-racial-disparities-on-efficacy-and-safety-outcomes-for-patients-with-rrmm-receiving-t-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hla-allele-tcr-v-and-j-gene-segment-usage-combinations-and-their-association-with-survival-in-neur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/murine-metastatic-embryonal-rhabdomyosarcoma-survival-and-immune-response-with-a-total-tumor-rna-lip 2026-08-24 monthly 0.7 https://rjrindex.com/articles/promoting-resilience-in-stress-management-prism-a-randomized-controlled-trial-of-a-psychosocial-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prevalence-and-outcomes-of-hypercalcemia-in-black-american-patients-hospitalized-with-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-role-of-circulating-tumor-dna-in-pmmr-locally-advanced-rectal-cancer-patients-receiving-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/complete-blood-count-as-a-prognostic-tool-for-nsclc-patients-treated-with-immune-checkpoint-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-durvalumab-plus-tremelimumab-versus-standard-chemotherapy-for-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characteristics-of-non-small-cell-lung-cancer-in-venezuela-a-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-liquid-biopsy-method-for-detecting-androgen-receptor-splice-variant-7-in-circulating-tumor-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nasopharyngeal-carcinoma-outcomes-in-a-predominantly-african-american-population-a-single-center-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-outcomes-of-second-primary-cancers-in-colorectal-cancer-patients-by-primary-tumor-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-due-to-laryngeal-cancer-among-older-adults-in-united-states-a-cdc-wond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-lipid-metabolism-related-gene-signature-associated-with-clinical-and-immune-features-in-lung-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-evaluating-the-safety-and-efficacy-of-autologous-tac-t-cells-in-subjects-with-clau 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-and-benefit-of-adjuvant-chemotherapy-in-early-vs-average-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-predictive-value-of-brca-mutation-on-survival-of-cancer-patients-treated-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-multiplex-immunofluorescence-analysis-of-the-tumor-microenvironment-for-predicting-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-incidence-of-immune-related-gastritis-and-duodenitis-in-a-single-tertiary-medical-center-a-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc-digital-interim-analysis-of-the-effectiveness-of-digital-health-interventions-on-the-quality-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-tumor-lysis-syndrome-associated-with-kinase-inhibitors-analysis-of-faers-and-real-world-dat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-phase-ii-study-of-anlotinib-and-toripalimab-in-patients-with-advanced-soft-tissue-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-policy-implementations-on-treatment-duration-for-patients-with-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-and-causes-of-early-death-among-patients-with-germ-cell-testis-tumors-gcts-an-intern 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-patterns-and-mortality-outcomes-in-young-lung-cancer-non-smokers-a-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-steap1-and-2-in-advanced-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-broad-based-genomic-sequencing-on-survival-outcomes-in-advanced-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-barriers-upfront-expense-payments-to-ease-the-economic-burden-for-clinical-trial-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-2-results-of-pt-112-monotherapy-in-late-line-metastatic-castration-resistant-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omitting-axillary-dissection-in-patients-with-1-2-sentinel-node-positive-breast-cancer-undergoing-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-level-qualitative-exploration-of-factors-influencing-breast-and-cervical-cancer-screening-up 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nivolumabrelatlimab-versus-nivolumabipilimumab-for-metastatic-melanoma-a-retrospective-propensit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-alk-clinical-characteristics-and-efficacy-of-targeted-therapy-in-nsclc-with-alk-fusions-other 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-human-whole-slide-image-wsi-and-ai-wsi-assessment-of-tumor-immune-microenvironment-in-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-addition-of-monoclonal-antibodies-to-chemotherapy-in-metastatic-early-onset-colorectal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiovascular-toxicity-of-fruquintinib-in-patients-with-colorectal-and-other-cancers-a-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/opinions-of-real-world-clinicians-regarding-visceral-crisis-in-hrher2-mbc-results-from-the-retra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hera-test-a-novel-precision-oncology-tool-using-breast-milk-for-early-detection-of-postpartum-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-benefits-of-trilaciclib-on-blood-product-utilization-and-neutropenic-fever-episodes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-a-selective-parp1-inhibitor-ace-86225106-in-patients-with-advanced-solid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-review-of-hereditary-leiomyomatosis-and-renal-cell-cancer-at-a-single-institution 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progesterone-receptor-expression-and-survival-outcomes-in-metastatic-breast-cancer-a-retrospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-genetics-evaluation-among-individuals-at-risk-for-lynch-syndrome-across-all-qualifying-indica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-treatment-outcomes-of-small-cell-carcinoma-of-the-small-intestine-colon-and-rectum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-maintenance-therapy-for-metastatic-urothelial-carcinoma-efficacy-analysis-and-sequential-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/crisis-within-a-crisis-a-cdc-wonder-analysis-of-the-pandemics-impact-on-cancer-and-cardiovascular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trem-1-upregulation-as-a-potential-predictive-immune-biomarker-of-pathologic-complete-response-pcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatoprotective-effects-and-safety-profile-of-donafenib-combined-with-transarterial-chemoembolizati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rationale-and-study-design-of-the-kov-hipec-02r-recover-a-randomized-multicenter-open-label-pha 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toward-manipulating-sex-hormones-to-modulate-the-adaptive-antitumor-immune-response-in-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cadonilimab-combined-with-gemcitabine-and-cisplatin-in-advanced-biliary-tract-cancer-bicurex-a-ph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-immunosurveillance-by-macrophage-in-supporting-therapeutic-strategies-usin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-risk-factors-and-mortality-of-stroke-in-polycythemia-vera-a-single-center-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/legend-a-phase-12-study-of-detalimogene-voraplasmid-eg-70-an-intravesical-monotherapy-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progress-in-the-management-of-primary-and-metastatic-cardiac-sarcoma-advancing-multidisciplinary-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/granisetron-transdermal-delivery-system-for-nausea-and-vomiting-prophylaxis-in-her2-positive-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-therapy-for-advanced-epithelioid-sarcoma-a-meta-analysis-of-effectiveness-and-safety-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-trends-in-race-and-gender-disparities-in-incidence-based-mortality-in-patients-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-pass-whole-methylome-sequencing-based-liquid-biopsy-for-metastatic-colorectal-cancer-monitoring 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-quality-of-life-outcomes-in-patients-with-head-and-neck-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-comprehensive-cancer-network-guideline-compliance-in-an-oncology-value-based-care-program-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-and-utilization-patterns-of-olaparib-in-patients-with-early-stage-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-and-timing-of-first-tumor-next-generation-sequencing-testing-ngs-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-immunochemotherapy-ict-in-patients-pts-with-metastatic-gastric-cancer-mgc-in-conte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuation-of-serplulimab-based-therapy-beyond-first-progression-in-advanced-gastricgastroesophag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-glucagon-like-peptide-1-agonists-on-mgus-progression-in-patients-with-type-2-diabetes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-the-novel-anti-llt1-antibody-zm008-alone-and-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-team-efficiency-for-genetic-risk-assessment-medical-oncology-led-germline-testing-for-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-toxicity-profiles-of-two-drug-versus-three-drug-neoadjuvant-chemotherapy-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-patterns-on-clinical-outcomes-in-patients-of-advanced-pancreatic-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-interruptions-in-chemotherapy-on-survival-for-patients-with-metastatic-or-recurrent-cervic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2-and-her3-expression-in-ovarian-cancer-evolution-across-chemotherapy-exposure-and-implications 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-medical-oncologists-exploring-the-impact-and-engagement-of-telegram-channels-for-profess 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-assessing-the-efficacy-of-combined-transarterial-chemoembolization-and-microwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-p53-protein-expression-in-endometrial-carcinoma-using-immunohistochemistry-a-study-fr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-supportive-care-breast-cancer-clinical-trial-enrollment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transformer-based-deep-learning-model-for-integrated-pathomics-and-radiomics-in-predicting-postopera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-breast-cancer-treatment-on-young-womens-body-image-and-sexual-health 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-hodgkin-lymphoma-related-mortality-in-the-united-states-over-the-last-three-decad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-dose-escalation-study-of-the-oral-dna-polymerase-theta-inhibitor-polqi-gsk4524101-ni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pronounced-gender-based-and-regional-disparities-in-lung-cancer-mortality-in-the-us-insights-from-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-continuous-zanubrutinib-vs-fixed-duration-venetoclax-in-combination-with-obinutuzumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evaluation-of-a-hyperselection-predictive-biomarker-for-anti-egfr-therapy-benefit-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/body-composition-and-allostatic-load-in-racially-and-ethnically-diverse-patients-with-metastatic-col 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-arm-iit-study-of-ha131-hepatic-arterial-infusion-in-combination-with-systemic-therapy-xe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-open-label-randomized-study-of-livmoniplimab-in-combination-with-budigalimab-versus-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-survival-in-malignant-meningiomas-a-machine-learning-approach 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-early-imaging-based-screening-on-outcomes-in-young-patients-with-von-hippel-lindau-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-validation-of-the-risk-estimation-of-tumor-recurrence-after-transplant-retreat-score-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/severe-sarcopenia-and-symptom-burden-prior-to-chemotherapy-among-older-adults-70-with-advanced-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-prediction-of-combined-pre-and-post-operative-ctdna-detection-in-non-small-cell-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-as-a-minimal-residual-disease-assessment-and-recurrence-risk-in-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-disparities-in-cardiovascular-mortality-among-breast-cancer-patients-a-25-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-pegylated-sn38-plx38a-and-rucaparib-in-itp53i-wild-type-en 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-chemotherapy-combined-with-radiofrequency-ablation-and-immunotherapy-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-early-detection-model-based-on-cfdna-methylation-and-fragmentation-features-for-liver-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-frailty-and-healthcare-resource-utilization-in-older-adults-with-pancreatic-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mixed-method-integration-of-clinician-distress-typologies-in-those-caring-for-seriously-ill-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/needed-leaders-and-leaders-needs-the-creation-of-a-quality-improvement-and-clinical-operations-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunohistochemistry-based-molecular-subtyping-in-muscle-invasive-bladder-cancer-predicting-respons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pelvic-lymph-node-dissection-on-survival-outcomes-in-non-muscle-invasive-bladder-cancer-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pet-metabolic-response-in-lugano-comparison-of-qualitative-and-quantitative-outcome-by-independent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-computational-insights-into-non-coding-rna-regulatory-networks-and-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-multimorbidity-related-mortality-among-patients-with-cancer-and-myocardial-infar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-health-care-providers-offer-advice-to-adolescents-about-nicotine-containing-product-use 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iia-study-of-adc1-vaccines-targeting-her2her3-combined-with-pembrolizumab-in-patients-with-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-germline-genetic-testing-in-diverse-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/protective-effects-of-gallic-acid-against-cadmium-induced-neuroinflammation-in-glioblastoma-cells 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-survival-outcomes-in-adrenocortical-carcinoma-a-comprehensive-analysis-of-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-genitourinary-oncology-a-bibliometric-study-and-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-trial-of-high-dose-methotrexate-hdmtx-followed-by-prophylactic-glucarpidase-in-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standard-versus-extended-pelvic-lymphadenectomy-in-patients-with-bladder-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-in-thyroid-cancer-patients-with-brain-metastases-a-systematic-review-and-individ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-incidence-and-mortality-rates-of-prostate-cancer-in-older-adults-using-autoregressive-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-adolescents-and-young-adults-with-carcinoma-of-unknown-primary-ins 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-germline-expedited-point-of-care-poc-genetic-testing-through-telehealth-in-the-veteran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/partnering-with-patients-to-deliver-window-of-opportunity-clinical-trials-in-immuno-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-triplet-therapy-based-on-organoid-drug-sensitivity-testing-in-lung-metastatic-hormone-se 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-urinary-tract-infections-on-in-hospital-outcomes-among-prostate-cancer-patients-an-nis-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-assessment-of-an-algorithm-based-decision-making-platform-for-patient-prioritization-dur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutation-rate-differences-across-populations-and-association-with-performance-disparities-in-patholo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rates-and-predictors-of-cancer-screening-in-california-ca-prisons 2026-08-24 monthly 0.7 https://rjrindex.com/articles/study-on-prevention-of-recurrence-in-patients-with-nmibc-for-whom-bcg-vaccine-treatment-failed-by-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-stereotactic-body-radiotherapy-sbrt-vs-sbrt-with-bridge-therapies-for-hep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extensive-lymph-node-dissection-and-overall-survival-in-colon-cancer-a-systematic-review-and-meta-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-data-from-ph1b-dose-optimization-trial-of-two-doses-of-th1902-sudocetaxel-zend 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benmelstobart-plus-carboplatinpaclitaxel-with-or-without-anlotinib-followed-by-maintenance-benmels 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systematic-review-of-car-t-cell-therapy-in-lung-cancer-move-forward-or-move-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/relapse-patterns-risk-factors-re-resectability-and-survival-after-curative-treatment-for-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psma-targeted-actinium-225-therapy-in-metastatic-castration-resistant-prostate-cancer-mcrpc-basel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ai-medical-scribes-on-physician-productivity-and-satisfaction-in-medical-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-heterogeneity-in-dmmrmsi-h-endometrial-cancer-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-and-clinical-outcomes-of-cmv-reactivation-in-car-t-therapy-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-network-meta-analysis-nma-of-efficacy-of-zanubrutinib-versus-fixed-duration-acalabrutinib-plus-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-histotme-predicted-immune-subtypes-and-immunotherapy-outcomes-using-human-interpretabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-hercules-study-a-prospective-real-world-evaluation-of-screening-whole-body-mri-swb-mri-for-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-analysis-of-tumor-microenvironment-in-advanced-pancreatic-cancer-unraveling-genomic-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sigvotatug-vedotin-sv-an-investigational-integrin-beta-6-ib6-directed-antibodydrug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoactivate-arm-c-phase-ii-trial-of-neoadjuvant-atezolizumab-and-tiragolumab-for-high-risk-operable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cognitive-outcomes-following-proton-vs-photon-radiotherapy-for-cns-non-germinomatous-germ-cell-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dermatologic-prophylaxis-and-impact-on-patient-reported-outcomes-in-first-line-iegfr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platform-study-of-circulating-tumor-dna-directed-adjuvant-chemotherapy-in-colon-cancer-claudia-colo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-dose-expansion-of-start-001-a-phase-12-study-of-invikafusp-alfa-star0602-a-first-in-cla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/congruence-between-circulating-tumor-dna-and-radiographic-response-during-treatment-of-advanced-sarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-ctdna-monitoring-and-prediction-of-anti-egfr-rechallenge-outcomes-in-rasbraf-wild-type 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-kras-g12c-inhibitor-mk-1084-for-ikrasi-g12c-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-adapted-oncologic-surgery-following-neoadjuvant-immunotherapy-and-chemotherapy-for-resectab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-machine-learning-predictions-of-treatment-response-and-survival-in-advanced-pancreatic-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-olaparib-temozolomide-and-pembrolizumab-in-a-phase-2-trial-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/head-and-neck-cancer-mortality-unequal-progress-and-emerging-disparities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-anti-cea-car-t-cells-to-prolong-relapse-free-survival-of-colorectal-cancer-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-molecular-characteristics-and-outcomes-of-early-onset-vs-late-onset-colon-cancer-a-sing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-and-evaluation-of-multi-cancer-early-detection-testing-at-the-dana-farber-cancer-inst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-deprivation-therapy-and-quality-of-life-a-concept-map-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-psma-pet-against-chaarted-criteria-in-an-enzamet-sub-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-determinants-of-pneumonitis-in-patients-with-cancer-treated-with-antibody-drug-conjugates 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-omics-based-insights-of-trop2-adc-in-non-small-cell-lung-cancer-with-or-without-actiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-the-cardiovascular-adverse-effects-of-bispecific-antibodies-in-malignant-hematology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/15-year-outcomes-for-women-with-premenopausal-hormone-receptor-positive-early-breast-cancer-bc-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quintessential-2-a-phase-3-study-comparing-efficacy-and-safety-of-arlocabtagene-autoleucel-arlo-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-promise-study-a-presurgical-randomized-clinical-trial-of-cebza-vs-placebo-in-postmenopausal-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-study-comparing-stereotactic-body-radiotherapy-sbrt-versus-conventional-pal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-socioeconomic-burden-of-ovarian-cancer-in-11-countries 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-analysis-and-prognostication-of-cholangiocarcinoma-a-seer-database-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adjuvant-chemotherapy-for-locally-advanced-cervical-carcinoma-an-updated-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/microbiome-metabolomics-analysis-for-biomarker-identification-in-liver-cancer-among-rio-grande-valle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potential-of-tumor-informed-ctdna-as-an-early-predictive-indicator-for-relapse-in-advanced-ovarian-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-brazilian-oncology-studies-over-the-last-5-asco-annual-meetings-and-their-representation-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-liver-cell-carcinoma-and-hepatic-failure-related-mortality-in-the-us-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-allostatic-load-and-measures-of-segregation-on-cancer-detection-and-false-positive-rate-af 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-accrual-of-a-cluster-randomized-controlled-trial-rct-comparing-an-educationally-enhance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inclusion-of-gestational-surrogacy-in-oncologist-led-fertility-counseling-at-cancer-diagnosis-a-nat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-use-of-peripheral-intravenous-catheters-piv-for-lymphoma-patients-receiving-anthracycline-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-among-oncology-patients-with-distinct-spiritual-well-being-profiles 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiles-in-prostate-cancer-patients-of-varying-measured-socioeconomic-inequality-a-retrosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-iil7i-germline-variants-with-immune-related-adverse-even 2026-08-24 monthly 0.7 https://rjrindex.com/articles/busulfan-and-cyclophosphamide-vs-busulfan-and-fludarabine-for-myeloablation-in-the-patients-of-acute 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoinduction-therapy-and-its-response-in-jehovahs-witnesses-with-acute-lymphoblastic-leukemia-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/voids-in-regulatory-guidance-for-development-of-theragnostic-radiopharmaceuticals-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-outcomes-of-sabr-in-intermediate-and-high-risk-prostate-cancer-without-adt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/does-xa-mark-the-spot-monitoring-anti-factor-xa-in-cancer-patients-receiving-low-molecular-weight-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-challenges-in-lmic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gprc5d-and-bcma-bi-specific-car-t-ex-vivo-study-to-simulate-early-to-late-line-multiple-myeloma-mm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-adjuvant-folfox-versus-flot-following-neoadjuvant-flot-in-locally-advanced-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strength-of-evidence-supporting-cancer-drug-approvals-in-china-2017-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-neoadjuvant-treatment-is-best-for-locally-advanced-esophageal-cancer-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-randomized-controlled-study-to-evaluate-efficacy-of-argon-beam-coagulation-versus-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-dose-reduction-of-monoclonal-antibodies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-institution-study-evaluating-the-fertility-of-young-adults-with-malignancy-treated-with-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-liver-specific-gene-expression-signatures-in-prostate-cancers-prior-to-liver-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-crispr-ko-screening-to-identify-novel-genes-and-pathways-potentially-contributing-to-cisplati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-niraparib-n-abiraterone-acetate-aa-plus-prednisone-p-for-hispaniclatino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trend-in-prostate-cancer-mortality-in-peru-during-the-period-2001-2020-and-its-prediction-to-2030 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-role-of-zeb2-upregulation-in-tam-polarization-and-immune-modulation-in-egfr-tki-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prostate-cancer-in-hiv-versus-non-hiv-population-nationwide-analysis-of-mortality-demographics-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/management-of-oligoprogressive-egfr-nsclc-in-the-age-of-osimertinib-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-preoperative-imaging-strategies-in-egfr-mutant-non-small-cell-lung-cancer-nsclc-a-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-results-from-a-phase-ii-study-of-dose-adjusted-etoposide-prednisone-vincristine-cyclophos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-suppression-combined-with-elective-nodal-irradiation-and-dose-escalated-prostate-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-non-coding-rna-based-regulatory-networks-in-cancer-metastasis-using-a-heterogeneous-hiera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-conversational-artificial-intelligence-ai-for-outpatient-malignant-bowel-obstruction-mb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-artificial-intelligence-model-to-predict-ki67-from-hampe-stained-whole-slides-images-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-obesity-in-hospitalized-pancreatic-cancer-patients-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-molecular-characteristics-of-patients-with-metastatic-pancreatic-ductal-adenoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-trials-to-clinics-real-world-outcomes-of-neoadjuvant-her2-directed-therapy-in-early-stage-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-dosage-modifications-and-impact-on-response-milestone-among-patients-with-cml-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-chemotherapy-versus-preoperative-chemoradiotherapy-in-resectable-esophageal-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-maintenance-olaparib-in-homologous-recombination-deficient-brca-negative-hi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-targetable-iegfri-mutations-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stepwise-ai-prompting-for-multiple-myeloma-imaging-classification 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionability-of-genomic-alterations-in-the-molecular-screening-and-therapeutics-most-program-in-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preference-for-first-line-treatments-of-alk-positive-metastatic-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mirna-mrna-regulatory-network-analysis-of-tumor-associated-mscs-and-cancer-associated-fibroblasts-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-vs-chemotherapy-in-elderly-patients-with-nsclc-a-comparative-analysis-of-survival-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tertiary-lymphoid-structures-and-their-association-with-immune-checkpoint-inhibitor-response-and-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-protein-energy-malnutrition-on-hospitalized-patients-with-breast-cancer-a-united-states-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-adjuvant-radiation-for-patients-with-hpv-related-oropharyngeal-cancer-first-planned-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-on-the-stage-at-diagnosis-and-mortality-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/infectious-events-in-patients-treated-for-malignancies-with-t-cell-engagers-immunotherapies-a-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b-study-to-assess-the-safety-of-neoadjuvant-trifluridinetipiracil-with-concurrent-radiation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-clinical-characteristics-and-outcomes-of-intracranial-metastases-icm-in-human-papill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-pyrotinib-for-advanced-salivary-duct-carcinoma-sdc-with-positive-her2-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olink-proteomics-analysis-to-identify-biomarkers-of-radiation-and-immunotherapy-induced-pneumonitis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-acetaminophen-regimen-to-prevent-cytokine-release-syndrome-with-teclistamab-or-talqueta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-alectinib-and-brigatinib-in-alk-positive-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-and-ethnic-disparities-in-clinical-outcomes-of-her2-positive-metastatic-breast-cancer-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-prognosis-of-spindle-cellsclerosing-rhabdomyosarcoma-a-report-from-the-chi 2026-08-24 monthly 0.7